Project/Area Number |
23K06738
|
Research Category |
Grant-in-Aid for Scientific Research (C)
|
Allocation Type | Multi-year Fund |
Section | 一般 |
Review Section |
Basic Section 50020:Tumor diagnostics and therapeutics-related
|
Research Institution | University of Tsukuba |
Principal Investigator |
ザボロノク アレクサンドル 筑波大学, 医学医療系, 助教 (20723117)
|
Co-Investigator(Kenkyū-buntansha) |
石川 栄一 筑波大学, 医学医療系, 教授 (30510169)
白川 真 福山大学, 薬学部, 講師 (40707759)
中井 啓 筑波大学, 医学医療系, 准教授 (50436284)
鶴淵 隆夫 筑波大学, 医学医療系, 講師 (70778901)
MATHIS BRYAN 筑波大学, 附属病院, 病院講師 (80794635)
|
Project Period (FY) |
2023-04-01 – 2026-03-31
|
Project Status |
Granted (Fiscal Year 2023)
|
Budget Amount *help |
¥4,680,000 (Direct Cost: ¥3,600,000、Indirect Cost: ¥1,080,000)
Fiscal Year 2025: ¥1,820,000 (Direct Cost: ¥1,400,000、Indirect Cost: ¥420,000)
Fiscal Year 2024: ¥1,560,000 (Direct Cost: ¥1,200,000、Indirect Cost: ¥360,000)
Fiscal Year 2023: ¥1,300,000 (Direct Cost: ¥1,000,000、Indirect Cost: ¥300,000)
|
Keywords | BNCT / liposomes / nanoparticles / tumor targeting / glioma |
Outline of Research at the Start |
Synthesis and application of liposome-based theranostic nanoparticle complex superior to existing compounds for boron neutron capture therapy (BNCT) implemented by our research group will solve the problem of large boron amount delivery and its retention in tumor cells during neutron irradiation needed for successful neutron capture reaction and dosimetry in cancer treatment using BNCT.
|